Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Svendborg – page 3

45 clinical trials in Svendborg, Denmark. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Svendborg at a glance
45
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

45 trials in Svendborg

Open in trial search

Psoriatic arthropathy

Not recruiting

Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Not Used Biologic Treatments

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:JNJ-77242113
  • Sponsor:Janssen Cilag International

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Hypertriglyceridaemia+1

Not recruiting

Study of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:ISIS 678354 sodium salt
  • Sponsor:Ionis Pharmaceuticals Inc.

Atrial fibrillation

Not recruiting

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen Cilag International

Arteriosclerosis

Not recruiting

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Rheumatoid arthritis

Not recruiting

Baricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Eli Lilly & Co.

Chronic kidney disease+1

Not recruiting

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Sarcoidosis

Not recruiting

Study on Long-term Safety of XTMAB-16 for Patients with Pulmonary Sarcoidosis with or without Extra-pulmonary Involvement

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:XTMAB-16
  • Sponsor:Xentria Inc.

Myocardial infarction

Not recruiting

Study on the Effects of Carvedilol, Metoprolol Tartrate, and Bisoprolol Fumarate in Patients After a Heart Attack with Normal Heart Pumping Function

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bisoprolol Fumarate
  • Sponsor:Frederiksberg Hospital

Study on the Effects of Spironolactone, Pioglitazone, and Metformin for Adolescent Girls and Young Women with Polycystic Ovary Syndrome (PCOS)

Investigational
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Metformin
  • Sponsor:Fundacio Sant Joan De Deu

Study on the Effects of AR1001 (Mirodenafil Dihydrochloride) for Patients with Early Alzheimer's Disease

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Mirodenafil Dihydrochloride
  • Sponsor:Aribio Co. Ltd.

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Svendborg

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on heart failure prevention and treatment of atherosclerotic cardiovascular disease. Studies are evaluating new therapeutic approaches for reducing major adverse cardiovascular events and improving patient outcomes.

  • Heart Failure Prevention
  • Atherosclerotic Disease Management
  • Acute Myocardial Infarction

Several trials are investigating novel compounds for preventing stroke and managing atrial fibrillation complications.

02 Rheumatology Studies

Research initiatives examining treatments for psoriatic arthritis and rheumatoid arthritis, with particular focus on biologic therapies and conventional treatment approaches.

  • Psoriatic Arthritis Treatments
  • Early Rheumatoid Arthritis Management
  • Biologic Therapy Evaluation

Studies are comparing various treatment strategies and investigating new therapeutic options for inflammatory arthritis conditions.

03 Neurological Disorders

Clinical research examining treatments for Alzheimer's Disease and stroke, including innovative therapeutic approaches and emergency interventions.

  • Early Alzheimer's Disease Treatment
  • Stroke Management
  • Cerebral Hemorrhage Interventions

Trials are evaluating both preventive measures and acute treatments for various neurological conditions.

04 Orthopedic Medicine

Studies focusing on improving outcomes in hip and knee surgery, including post-operative care and pain management strategies.

  • Hip Fracture Recovery
  • Joint Replacement Outcomes
  • Post-Surgical Pain Management

Research includes evaluation of various treatment approaches for improving mobility and recovery after orthopedic procedures.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.